GoCo House Lunch Launch took place and we were there from Ribocure Pharmaceuticals to meet our future neighbours and potential collaborators. The excitement is high to expand our business and for the transition in to our new facilities in GoCo Clinic in June!
Ribo announces authorization to start a Phase I clinical trial in Sweden for siRNA drug RBD7007 targeting Complement Factor 5, C5
On September 10, 2024, Ribocure Pharmaceuticals AB and Suzhou Ribo